Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Read more at CNBC
-
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Business - CNBC - October 31 -
Coca-Cola tops earnings estimates, as higher prices offset sluggish demand
Business - CNBC - October 23 -
Merck’s stock slides as Q3 earnings beat estimates, but company lowers guidance
Business - MarketWatch - October 31 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Business - MarketWatch - October 30 -
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Business - CNBC - October 29 -
GSK cuts vaccine sales target on reduced demand
Business - MarketWatch - October 30 -
Sanofi Earnings Boosted by Early Vaccine Sales
Business - The Wall Street Journal - October 25 -
Samsung falls short of expectations as chipmaker fails to reap AI benefits
World - Financial Times - October 31
More from CNBC
-
Target's recent trade imports data tells the real story behind massive earnings miss
Business - CNBC - 32 minutes ago -
Home sales surged in October, just before mortgage rates jumped
Business - CNBC - 14 minutes ago -
Bitcoin hits fresh record, races toward $100,000 as rally continues
Business - CNBC - 32 minutes ago -
Trump and Fed Chair Powell could be set on a collision course over interest rates
Business - CNBC - 1 hour ago -
CFPB expands oversight of digital payments services including Apple Pay, Cash App, PayPal and Zelle
Business - CNBC - 24 minutes ago